Less Ads, More Data, More Tools Register for FREE

Pin to quick pickseEnergy Group Regulatory News (EAAS)

Share Price Information for eEnergy Group (EAAS)

Share Price is delayed by 15 minutes
Get Live Data
5.05    0.00 (0.00%)
Bid:
4.80
Ask:
5.30
Spread: 0.50 (10.417%)
Market Cap: £19.55m
EAAS Live PriceLast checked at - London Stock Exchange

Intraday eEnergy Group Share Chart

Agreement to Develop Mining Projects

27 Aug 2009 12:16

RNS Number : 1167Y
Alexander Mining PLC
27 August 2009
 



27 August 2009

Alexander Mining plc

("Alexander" or the "Company")

Agreement to Develop Mining Projects with MetaLeach's Proprietary Leaching Technologies

Alexander Mining plc is pleased to report that its wholly owned subsidiary MetaLeach Limited ("MetaLeach") has signed a twelve months commercial agreement with RPT Resources Ltd. ("RPT", listed on the TSX Venture Exchange - code RPT ). The principal features of the agreement are as follows:

RPT to pay MetaLeach a consultancy fee of US$300,000 per annum for information regarding potential mineral properties which may be suitable for the use of MetaLeach's proprietary leaching technologies.

RPT can select properties for acquisition and will be responsible for funding initial acquisition costs and for funding the development of a selected property through to commercial production.

MetaLeach will provide RPT with technical/testwork services on its normal commercial terms in relation to the application of the leaching technologies to each selected property.

MetaLeach will provide a licence for the use of its leaching technologies only on the selected property to enable the property to be developed and for commercial production to proceed.

RPT and MetaLeach will share profits and gains from a selected property, after crediting RPT with all acquisition and subsequent development costs, in the ratio 80 per cent & 20 per cent respectively. 

The licence will be at no cost to RPT, but if third parties have an interest in the selected property the licence will contain royalty obligations reflecting the extent of the third party interests.

Martin Rosser, CEO of Alexander, said: "We welcome this commercial agreement with RPT as an excellent way of accelerating the commercialisation of our leaching technology for mutual benefit. It allows us to participate in any future profits and gains via a significant equity stake in suitable properties/projects but with a negligible cost to Alexander. We have identified many attractive opportunities in different regions of the world suitable for acquiring direct equity interests in copper and zinc properties and development projects. In turn, RPT brings its valuable financial resources and equity capital markets experience to this exercise and we are already presenting properties, with excellent prospects, for their consideration. Meanwhile, the global licensing of our technology, which is aimed at generating a long term royalty stream, continues to be a business priority, and is progressing well." 

Under the agreement, which can be mutually extended after twelve months, MetaLeach will provide RPT with information regarding potential mineral properties which may be suitable for the use of MetaLeach's proprietary leaching technologies (in particular its AmmLeach® process), and which could be instrumental in the financially viable development of the properties.

RPT will be entitled to select one or more properties in which it wishes to acquire an interest and it will be responsible for funding the initial acquisition costs. RPT will also fund, or be responsible for procuring funding for, the development of a selected property through to commercial production.

MetaLeach will assist in the negotiations for the acquisition of an interest in the potential properties. Until RPT has had an opportunity to review the suitability of each of the potential properties, MetaLeach agrees not to provide any information with respect to that potential property to any other company, individual or other entities. In the event that a potential property is not selected for acquisition by RPT within three months, then MetaLeach shall be free to provide details to other parties. MetaLeach is obligated to provide information regarding at least three properties in each of the first and second six months periods of the agreement.

In consideration for the property identification service, RPT will pay MetaLeach a consultancy fee of US$300,000 per annum, of which the first US$150,000 is payable on signature of the formal agreement and then payable in equal monthly instalments commencing six months thereafter.

MetaLeach will provide RPT with technical assistance services, including conducting testwork, in relation to the application of the leaching technologies to each selected property, on MetaLeach's normal commercial terms. In addition, MetaLeach will provide a licence for the use of its leaching technologies on the selected property at no cost to RPT to enable the property to be developed and for commercial production to proceed. The no-cost licence entitlement shall continue in force only if RPT and MetaLeach together own the entire interest in the selected property.

In consideration for the above, RPT and MetaLeach will share profits from a selected property in the ratio 80 per cent & 20 per cent respectively. Profits and gains will be shared after crediting RPT with all acquisition costs. RPT and MetaLeach will be diluted proportionately by external investors in any selected property.

In connection with this transaction, a finder's fee is payable, which will be settled by issuing 500,000 new ordinary shares ("Shares") in the capital of the Company to Morgarlan Limited. Application has been made to the London Stock Exchange for the Shares to be admitted to trading on AIM. The Shares will when issued rank pari passu with the Company's existing issued ordinary shares. Dealings in the Shares are expected to commence on 3 September 2009 ("Admission").

Following Admission, the Company's enlarged issued share capital will comprise 135,034,667 ordinary shares with voting rights. The Company does not hold any shares in treasury. This figure of 135,034,667 ordinary shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FSA's Disclosure and Transparency Rules.

For further information please contact:

Martin Rosser

Matt Sutcliffe

Chief Executive Officer

Executive Chairman

Mobile: + 44 (0) 7770 865 341

Mobile: +44 (0) 7887 930 758

Alexander Mining plc

1st Floor

35 Piccadilly

London

W1J 0DW

Tel: +44 (0) 20 7292 1300

Fax: +44 (0) 20 7292 1313

Email: mail@alexandermining.com

Website: www.alexandermining.com

Nominated Advisor and Broker

Alasdair Younie/John Prior

Arbuthnot Securities Limited

Arbuthnot House

20 Ropemaker Street

London

EC2Y 9AR

Tel: +44 (0) 20 7012 2000

Public/Media Relations

Tim Blackstone

Britton Financial PR

62 Britton Street

London

EC1M 5UY

Tel: +44 (0) 20 7242 9786

Mobile: +44 (0) 7957 140 416

Email: tim@brittonpr.com

Appendix 

Background notes for editors

RPT Resources Ltd.

RPT Resources Ltd (http://www.rptresources.com) is a well financed junior explorer listed on the TSX Venture exchange. RPT looks to maximize shareholder value by acquiring, exploring and developing world class projects in the resource sector. With approximately C$13 million in cash, RPT is well placed to take advantage of the outstanding opportunities arising in the currently favourable market conditions. RPT currently has projects in the uranium, oil and gas, and platinum-palladium sectors. Its flagship project is the Dorion property, which lies 4km along strike and to the North East of Magma Metal's Thunder Bay North (TBN) polymetallic project in Ontario, Canada. The TBN project recently won the 2008 Discovery of the Year Award presented at this year's North Western Prospectors Association conference.

Alexander Mining plc

Alexander, through its wholly owned subsidiary MetaLeach Limited, is solely focused on the commercialisation of its proprietary mineral processing technologies. Alexander has already received test-work payments and the pipeline of amenability test-work programmes is increasing steadily. A major campaign to grow this revenue stream is under way, with the aim of securing future royalties and/or free carried equity interests in attractive base metals projects and/or mines.

AmmLeach®, for which patents are pending, has the potential to revolutionise the extraction processes for high acid consuming copper and zinc oxide deposits. The operating cost differential between AmmLeach® and conventional heap leaching treatment methods for high sulphuric acid consuming ores and the AmmLeach® ammonia process is a significant order of magnitude in AmmLeach®'s favour.

The AmmLeach® process was developed as a result of Alexander's successful pilot plant demonstration at its Leon copper project in Argentina and subsequent research and development. As well as copper oxides, AmmLeach® has excellent potential for developing a new SX-EW process for producing high purity zinc metal or an intermediate product at the mine. 

The zinc process has been trialled successfully on a bench scale and larger scale test-work is imminent. The AmmLeach® process leaches common zinc oxide minerals with high extraction efficiencies and offers a potentially economic processing route for many zinc oxide deposits that are currently economically unviable.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGRBBGDIUBDGGCR
Date   Source Headline
1st Jun 20267:00 amRNSPublication of AR, Notice of AGM and Board Update
18th May 20267:00 amRNSDirectorate change
13th May 20267:00 amRNSBoard changes
30th Apr 20267:00 amRNSFinal Results for the Year Ended 31 December 2025
16th Apr 20267:00 amRNSQ1 Trading Update, Revenue Recognition & Outlook
4th Mar 20267:00 amRNS-RContract wins
23rd Feb 20267:00 amRNSLoan Agreement
23rd Jan 20267:00 amRNSTrading Update
22nd Jan 20267:00 amRNSLaunch of new funding solution and first contract
19th Jan 20267:00 amRNSAppointment of Non-Executive Director
15th Dec 20257:00 amRNSFY Trading Update
27th Nov 20257:00 amRNSDirectorate change
17th Nov 20253:20 pmRNSAward of Options
12th Nov 20254:38 pmRNSSolar Agreement, Loan Agreement, Grant of Warrants
29th Oct 202511:39 amRNSHolding(s) in Company
27th Oct 20257:00 amRNS-RLargest EV Charging Project to Date with NHS
23rd Oct 20252:10 pmRNSHolding(s) in Company
20th Oct 20251:28 pmRNSHolding(s) in Company
1st Sep 20257:00 amRNSPreferred supplier for major solar contract
22nd Aug 20253:04 pmRNSHolding(s) in Company
21st Aug 20253:09 pmRNSHolding(s) in Company
19th Aug 202510:50 amRNSHolding(s) in Company
7th Aug 202512:13 pmRNSHolding(s) in Company
31st Jul 20255:17 pmRNSResult of AGM
22nd Jul 20257:00 amRNSUnaudited HY Results - Six Months Ended 30.06.25
3rd Jul 202510:46 amRNSNotice of AGM
30th Jun 20257:00 amRNSNotice of Results
13th Jun 20259:30 amRNSNotice of FY Results and Investor Presentation
3rd Jun 20259:25 amRNSHolding(s) in Company
20th May 202511:10 amRNSHolding(s) in Company
16th May 20257:00 amRNS£100m Partnership with Redaptive
7th Apr 20257:00 amRNS-RFramework win
26th Mar 20257:00 amRNS-RLaunch of SolarLife
24th Mar 20257:00 amRNS-RContracts wins and appointment to a Framework
11th Mar 20257:00 amRNS-RContract Wins
12th Feb 202511:17 amRNSHolding(s) in Company
3rd Feb 20257:00 amRNS-RInvestor Meet Company Presentation
30th Jan 20257:00 amRNSTrading update
19th Dec 20241:45 pmRNSAward of Options and PDMR Transactions
28th Nov 20247:00 amRNS-RLED Conversion Contract in Further Education
15th Oct 202410:45 amRNSHolding(s) in Company
1st Oct 20247:00 amRNSDirector appointment - additional information
30th Sep 20247:00 amRNSResults for the six months ended 30 June 2024
6th Sep 20247:00 amRNSHolding(s) in Company
8th Aug 20247:00 amRNSInvestor Presentations
26th Jul 20247:00 amRNSH1 24 Trading Update
28th Jun 20243:03 pmRNSResult of AGM
13th Jun 20247:00 amRNSNotice of General Meeting
30th Apr 20247:01 amRNSFinal Results for the 18 months ended 31 Dec 2023
22nd Apr 20247:00 amRNSMajor Contract Win with Spire Healthcare

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.